Browse 37 archived publications.

2020-10-05

PharmaVentures advises Novartis on the sale of its manufacturing facility in Barberà del Vallès to Siegfried Holding AG

2020-03-26

PharmaVentures’ Industry Insight: We predict that licensing and partnering activity will remain steady in 2020

2018-09-06

PharmaVentures advises Vital Foods on the sale of its Zyactinase-based digestive health product asset portfolio to Mundipharma.

2018-08-20

PharmaVentures advises SalvaRx Group plc on the acquisition of SalvaRx Ltd by Portage Biotech Inc.

2018-04-11

PharmaVentures Strengthens Its First-Class Strategy Consulting & Dealmaking Capabilities

2018-03-19

Video Interview: NetScientific, Fighting chronic diseases on three fronts.

2017-12-15

PharmaVentures Capital Ltd advises Biosceptre International Ltd, a clinical stage oncology company, on its Series A private placement by Tuspark S&T

2016-10-28

PharmaVentures advises IDT Australia on the divestment of CMAX clinical trial business to the Japanese company I’rom Group Co. Ltd.

2016-07-27

PharmaVentures advises the Baylor Scott & White Research Institute on collaboration with Abzena plc and creation of Denceptor Therapeutics

2016-07-21

PharmaVentures expands corporate advisory services through new UK Financial Conduct Authority (FCA) regulated firm

2016-03-22

PharmaVentures advises 3Legs Resources on its acquisition of the Immuno-Oncology company SalvaRx who announced its admission for trading on AIM today

2016-02-04

PharmaVentures advises Transgene on the sale of their biopharmaceutical manufacturing facility

2015-12-17

PharmaVentures advises Stericool on sale to Sweden’s Getinge Group

2015-09-16

MDxHealth Acquires NovioGendix to Expand Uro-Oncology Product Offering

2015-09-04

PharmaVentures’ Latest Deal: Douglas Pharmaceuticals acquires Vital Foods’ Phloe product line in New Zealand

2015-06-30

PharmaVentures Completes M&A Deal for Technology in the Stem Cell and Regenerative Medicine Sector

2015-05-07

Are you Planning to Divest R&D or Manufacturing Facilities?

2015-05-05

PharmaVentures are Media Partners at the World Stem Cells & Regenerative Medicine Congress 2015

2015-03-04

PharmaVentures further strengthens its Business Development team

2015-02-11

PharmaVentures increases life science presence in the USA

2015-01-27

Client News Update: Novartis enters exclusive talks on the potential sale of its UK Horsham site to the University of Brighton

2015-01-02

Season’s Greetings from PharmaVentures 2014

2014-10-06

Convergence of Healthcare with ICT accelerates

2014-10-01

PharmaVentures Acts As Advisor to Plethora Solutions in deal with Recordati

2014-09-24

PharmaVentures increases its Asia-Pacific presence

2014-09-16

PharmaVentures Advises MedGenesis in Agreement with Pfizer for Its Potential Therapy for Parkinson’s Disease

2014-09-16

PharmaVentures strengthens its expertise in early stage deal making

2014-08-27

PharmaVentures acts as exclusive advisor on the sale of Medical Insight to Karos Health

2014-07-07

PharmaVentures Divests Manufacturing Facility for Major Pharma Client

2014-05-16

PharmaVentures expands reach to Latin America

2014-05-09

PharmaVentures engaged in valuation of assets for newly AIM listed Tiziana Life Sciences.

2014-04-11

Novartis appoints PharmaVentures as advisors on the future of its UK Horsham site

2014-04-02

Pharma is attracted to early-stage antibody deals in Oncology

2013-12-18

Season’s Greetings from PharmaVentures

2013-12-11

PharmaVentures Strengthens M&A Team

2013-10-23

PharmaVentures advised Nanosight on its sale to Spectris plc.

2013-10-23

PharmaVentures advised Dogu Tip on its sale to Gulf Capital